Recently, the "ChemPharm Annual Summit 2018" officially released the list of "Excellent Enterprises and Excellent Product Brands in China's Chemical Pharmaceutical Industry in 2018". Among the enterprises named, China Grand Enterprises, Inc. (Pharmaceuticals) was honored with the title of being named one of the "Top Ten Chinese Pharmaceutical Industry Enterprise Groups" with its excellent comprehensive strength such as excellent overall performance, excellent brand reputation, deep industry influence and high social responsibility.

The list was jointly compiled by the China Pharmaceutical Industry Association, the China Association of Pharmaceutical Commerce, the China Nonprescription Medicines Association, the China Pharmaceutical Enterprise Development Promotion Association and Reed Sinopharm Exhibitions Co., Ltd, and was finally approved by the Brand Recommendation Expert Committee in accordance with the principles of “objectivity, science and fairness”.

In addition, Grand Pharmaceutical (China) Co., Ltd., a member of China Grand Enterprises, Inc. also ranked 34th among the "Top 100 Industrial Enterprises with the Strongest Comprehensive Strength in China's Chemical Pharmaceutical Industry in 2018" and was awarded "Excellent Preparation Export-Oriented Corporate Brand of China's Chemical and Pharmaceutical Industry in 2018", "Excellent Raw Material Export-Oriented Corporate Brand of China’s Chemical Pharmaceutical Industry in 2018", "Excellent Corporate Brand for Promoting Integration of Informatization and Industrialization in China’s Chemical Pharmaceutical Industry in 2018" and other honorary titles with strong brand advantages and solid corporate strength. Grand Pharmaceutical (China) Co., Ltd. won the "Special Green Pharmaceutical Award of China’s Chemical Pharmaceutical Industry in 2018" with  its "Production of Amino Acids by Fermentation and Enzymatic Conversion Technology". It also won the title of "Excellent Product Brand of Medicines for Other Departments of China’s Chemical Pharmaceutical Industry in 2018" with “Eucalyptol, Limonene and Pinene Enteric Soft Capsule” (trade name: Qienuo)

As an important business area of China Grand Enterprises, Grand Health has always regarded innovation as a strategic focus and safeguards the company’s sustainable development by conducting independent research and development, collaborative innovation in production, education and research, international cooperation and other modes of development. The pharmaceutical health business field of China Grand Enterprises has seen the formation of a medical health business model integrating R&D, production and sales. This model incorporates Chinese medicine, chemical medicine and biological medicine for both domestic and international markets. Grand Health adheres to the supremacy of quality, pursues development with innovation, always regards “serving society” as its highest mission, establishes future business with innovative cooperation and continues to make major contributions to society.